Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 19/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 17/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11330348 | 0.79 | CA2 (0.67) | PTGS1PTGS2CA2 | |
| SCHEMBL7524156 | 0.78 | PTPN1 (0.63) | PTGS1PTGS2CA2 | |
| SCHEMBL2079574 | 0.74 | CA2 (0.49) | PTGS1PTGS2CA2 | |
| SCHEMBL4968060 | 0.74 | PTGS1 (0.50) | PTGS1PTGS2CA2 | |
| SCHEMBL4972432 | 0.72 | PTGS1 (0.70) | PTGS1PTGS2CA2 | |
| SCHEMBL2080327 | 0.72 | CA2 (0.47) | PTGS1PTGS2CA2 | |
| SCHEMBL12778979 | 0.71 | PTGS1 (0.44) | PTGS1PTGS2CA2 | |
| SCHEMBL2076986 | 0.70 | MRGPRX1 (0.46) | PTGS1PTGS2CA2 | |
| SCHEMBL27241 | 0.70 | ABL1 (0.47) | PTGS1PTGS2CA2 | |
| SCHEMBL2080151 | 0.70 | CA2 (0.45) | PTGS1PTGS2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060281695-A1 | Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives | SCHERING-PLOUGH ANIMAL HEALTH CORPORATION | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060281695-A1 | Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives | ELANE, CTRL, PIGO | PTGS1 296/4885PTGS2 1435/4885CA2 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.